Johnson & Johnson's single-dose COVID-19 vaccine trial reaches full enrollment
December 19 2020, 08:00
Johnson & Johnson announced it has fully enrolled its late-stage single-dose coronavirus vaccine trial with about 45,000 participants.
Johnson & Johnson announced it has fully enrolled its late-stage single-dose coronavirus vaccine trial with about 45,000 participants.
Source:
FOX News